• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 32 of 100
Seniors face steep drug costs as Congress stalls on capping Medicare out-of-pockets
HealthSeniors face steep drug costs as Congress stalls on capping Medicare out-of-pockets
By Harris Meyer and Kaiser Health NewsDecember 28, 2020
AstraZeneca-Oxford COVID vaccine could get U.K. approval as soon as this week
HealthAstraZeneca-Oxford COVID vaccine could get U.K. approval as soon as this week
By Viren Vaghela, Thomas Penny and BloombergDecember 28, 2020
COVID vaccine CDC allergies
HealthWhat to know about the CDC’s new COVID vaccine guidance for people with health conditions
By Sy MukherjeeDecember 27, 2020
Doctors and patients face a painkiller crisis, even as they fight COVID
CommentaryDoctors and patients face a painkiller crisis, even as they fight COVID
By Joseph StaufferDecember 16, 2020
Big Pharma’s new CEOs must step up to erase inequities in drug access
CommentaryBig Pharma’s new CEOs must step up to erase inequities in drug access
By Jayasree K. IyerDecember 15, 2020
Photo of AstraZeneca CEO Pascal Soriot
FinanceWhy shareholders had a severe adverse reaction to AstraZeneca’s Alexion deal
By Jeremy KahnDecember 14, 2020
Coronavirus
HealthThe science behind the leading COVID vaccines will lead to faster manufacturing
By Sy MukherjeeDecember 5, 2020
Protein folding image for Eye on A.I.
NewslettersLessons from DeepMind’s breakthrough in protein-folding A.I.
By Jeremy KahnDecember 1, 2020
Know when to fold ’em: How a company best known for playing games used A.I. to solve one of biology’s greatest mysteries
TechKnow when to fold ’em: How a company best known for playing games used A.I. to solve one of biology’s greatest mysteries
By Jeremy KahnNovember 30, 2020
DeepMind’s new protein-folding A.I. is already helping in the fight against COVID-19
HealthDeepMind’s new protein-folding A.I. is already helping in the fight against COVID-19
By Jeremy KahnNovember 30, 2020
A picture of a protein shape.
TechIn a major scientific breakthrough, A.I. predicts the exact shape of proteins
By Jeremy KahnNovember 30, 2020
COVID vaccine FDA timeline
HealthIt may be a matter of weeks, not months, before Americans can start getting COVID vaccines
By Sy MukherjeeNovember 28, 2020
Syringe shown against the AstraZeneca logo
HealthAstraZeneca eyes another global trial for its COVID vaccine following dosage blip
By Suzi Ring, James Paton and BloombergNovember 27, 2020
For AstraZeneca’s COVID vaccine, less may be more—and that’s puzzling researchers
HealthFor AstraZeneca’s COVID vaccine, less may be more—and that’s puzzling researchers
By Angelica LaVito, John Lauerman and BloombergNovember 25, 2020
Trump administration and drug prices transparency
HealthNew Trump administration rule directs insurers to reveal what they pay for prescriptions
By Harris Meyer and Kaiser Health NewsNovember 19, 2020
1...
  • 30
  • 31
  • 32
  • 33
  • 34
...100
Most Popular
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Success
Now worth $200 million, Sarah Jessica Parker credits being ‘one of eight kids that struggled financially’ for her hunger, ambition, and work ethicplaceholder alt text
By Orianna Rosa RoyleJune 24, 2026
Success
Ikea’s billionaire founder was so frugal that he bought clothes from flea markets and took free salt and pepper from restaurantsplaceholder alt text
By Orianna Rosa RoyleJune 25, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.